Twilio (NYSE:TWLO) & Black Titan (NASDAQ:BTTC) Head-To-Head Review

Black Titan (NASDAQ:BTTC) and Twilio (NYSE:TWLO) are both technology companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

Analyst Recommendations

This is a summary of current ratings and target prices for Black Titan and Twilio, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Black Titan	1	0	0	0	1.00
Twilio	2	2	22	2	2.86

Twilio has a consensus target price of $258.65, suggesting a potential downside of 8.03%. Given Twilio’s stronger consensus rating and higher probable upside, analysts clearly believe Twilio is more favorable than Black Titan.

Risk & Volatility

Black Titan has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500. Comparatively, Twilio has a beta of 1.35, indicating that its stock price is 35% more volatile than the S&P 500.

Valuation & Earnings

This table compares Black Titan and Twilio”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Black Titan	$180,000.00	26.45	-$4.71 million	($2.95)	-0.15
Twilio	$5.07 billion	8.52	$33.83 million	$7.18	39.17

Twilio has higher revenue and earnings than Black Titan. Black Titan is trading at a lower price-to-earnings ratio than Twilio, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Black Titan and Twilio’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Black Titan	N/A	N/A	N/A
Twilio	20.61%	5.09%	4.15%

Insider & Institutional Ownership

84.3% of Twilio shares are owned by institutional investors. 0.7% of Black Titan shares are owned by company insiders. Comparatively, 0.2% of Twilio shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Twilio beats Black Titan on 13 of the 15 factors compared between the two stocks.

About Black Titan

Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.

About Twilio

Twilio Inc., together with its subsidiaries, provides customer engagement platform solutions in the United States and internationally. It operates through two segments, Twilio Communications and Twilio Segment. The company provides various application programming interfaces and software solutions for communications between customers and end users, including messaging, voice, email, flex, marketing campaigns, and user identity and authentication. It also offers software products to build direct, personalized relationships with their end users, such as segment, a platform that provides tools for first-party data by unifying real-time information collected; and engage, an automation platform for the delivery of omnichannel campaigns. Twilio Inc. was incorporated in 2008 and is headquartered in San Francisco, California.